Achieve Life Sciences, Inc. QUIT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 83.80% | -635.34% | 30.65% | -1.53% | -13.55% |
| Total Depreciation and Amortization | 5.26% | 0.00% | 0.00% | 5.56% | -1.82% |
| Total Amortization of Deferred Charges | 25.00% | 0.00% | 9.09% | -15.38% | -7.14% |
| Total Other Non-Cash Items | -100.27% | 6,682.68% | -168.55% | -42.15% | -18.06% |
| Change in Net Operating Assets | 5,323.94% | -98.28% | 186.22% | -903.69% | 0.34% |
| Cash from Operations | 22.46% | -55.47% | 61.44% | -58.65% | -24.94% |
| Capital Expenditure | -106.25% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 98.82% | -1,065.17% | 1,916.38% | 105.60% | -288.78% |
| Cash from Investing | 98.80% | -1,065.28% | 1,913.54% | 105.60% | -288.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -86.08% | 802,080.95% | -98.34% | -68.75% | -90.19% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -87.19% | 802,080.95% | -99.66% | 54.95% | -90.19% |
| Foreign Exchange rate Adjustments | -200.00% | 400.00% | -125.00% | 500.00% | -150.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -41.84% | 169.96% | 166.94% | 44.84% | -151.33% |